To further elucidate the role of the METTL3-apoptosis pathway in driving the progression of ESCC, we also detected the expression of CASP9 and BIRC3 in the xenograft model with METTL3-ablated ESCC and control cells. The gene discussed is BIRC3; the disease is esophageal squamous cell carcinoma.